Thompson Davis & Co., Inc. Profound Medical Corp. Transaction History

Thompson Davis & Co., Inc.

$152 Million
Q3 2025

A detailed history of Thompson Davis & Co., Inc. transactions in Profound Medical Corp. stock. As of the latest transaction made, Thompson Davis & Co., Inc. holds 208,720 shares of PROF stock, worth $1.39 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

208,720

Previous 210,495 0.84%

Holding current value

$1.39 Million

Previous $1.24 Million 14.91%

% of portfolio

0.69%

Previous 0.88%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$3.87 - $6.13 $6,869 - $10,880	-1,775 Reduced 0.84%	208,720 $1.06 Million
Q2 2025 Aug 20, 2025	SELL	$4.04 - $6.86 $242,501 - $411,771	-60,025 Reduced 22.19%	210,495 $1.24 Million
Q2 2025 Aug 08, 2025	BUY	$4.04 - $6.86 $269,346 - $457,356	66,670 Added 32.71%	270,520 $1.6 Million
Q1 2025 May 13, 2025	BUY	$5.81 - $7.9 $125,234 - $170,284	21,555 Added 11.82%	203,850 $1.19 Million
Q4 2024 Feb 03, 2025	BUY	$6.98 - $8.96 $561,157 - $720,339	80,395 Added 78.9%	182,295 $1.37 Million
Q3 2024 Nov 08, 2024	BUY	$7.47 - $11.18 $202,437 - $302,978	27,100 Added 36.23%	101,900 $811,000
Q2 2024 Jul 23, 2024	BUY	$7.25 - $9.07 $44,587 - $55,780	6,150 Added 8.96%	74,800 $627,000
Q1 2024 May 02, 2024	BUY	$7.3 - $9.46 $1,642 - $2,128	225 Added 0.33%	68,650 $585,000
Q4 2023 Feb 05, 2024	SELL	$7.85 - $11.18 $140,907 - $200,681	-17,950 Reduced 20.78%	68,425 $580,000
Q3 2023 Nov 09, 2023	SELL	$7.91 - $13.27 $751 - $1,260	-95 Reduced 0.11%	86,375 $881,000
Q2 2023 Jul 13, 2023	BUY	$9.27 - $14.88 $100,811 - $161,820	10,875 Added 14.39%	86,470 $1.12 Million
Q1 2023 May 09, 2023	BUY	$8.85 - $13.27 $38,055 - $57,061	4,300 Added 6.03%	75,595 $702,000
Q4 2022 Feb 06, 2023	BUY	$3.18 - $10.91 $161,254 - $553,235	50,709 Added 246.33%	71,295 $776,000
Q3 2022 Nov 09, 2022	SELL	$3.99 - $9.3 $15,265 - $35,581	-3,826 Reduced 15.67%	20,586 $83,000
Q2 2022 Aug 04, 2022	SELL	$6.34 - $9.53 $340,267 - $511,475	-53,670 Reduced 68.74%	24,412 $178,000
Q2 2022 Aug 02, 2022	BUY	$6.34 - $9.53 $294,068 - $442,029	46,383 Added 146.32%	78,082 $569,000
Q1 2022 May 13, 2022	SELL	$8.16 - $11.33 $11,742 - $16,303	-1,439 Reduced 4.34%	31,699 $285,000
Q4 2021 Feb 14, 2022	BUY	$10.38 - $15.2 $343,972 - $503,697	33,138 New	33,138 $374,000

Others Institutions Holding PROF

# of Institutions

Shares Held

11.2M

Call Options Held

Put Options Held

View Full List

About Profound Medical Corp.

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $139M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

More about PROF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Davis & Co., Inc. with notifications on news.

Account

Thompson Davis & Co., Inc. Profound Medical Corp. Transaction History